-
Information-Publications
-
Kdm4a is an activity downregulated barrier to generate engrams for memory separationDetails
-
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolismDetails
-
FBXO22 is a potential therapeutic target for recurrent chondrosarcomaDetails
-
Hyperlanins A and B, Two Highly Rearranged Meroterpenoids from Hypericum lancasteriDetails
-
PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/BNIP3L-dependent mitophagyDetails
-
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent InhibitorDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands